Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Sosei Group ( (JP:4565) ) has issued an announcement.
Nxera Pharma Co. Ltd announced the receipt of dividends amounting to JPY 8,193 million from its subsidiary, Nxera Pharma UK Limited. The dividend income of JPY 2,793 million will be recorded as non-operating income in the company’s non-consolidated financial statements for the fiscal year ending December 31, 2025, with no impact on its consolidated financial results.
The most recent analyst rating on (JP:4565) stock is a Buy with a Yen1400.00 price target. To see the full list of analyst forecasts on Sosei Group stock, see the JP:4565 Stock Forecast page.
More about Sosei Group
Nxera Pharma is a technology-driven biopharmaceutical company focused on developing and commercializing innovative specialty medicines to address unmet medical needs globally, particularly in Japan and the broader APAC region. The company leverages its NxWave™ discovery platform to advance a robust pipeline targeting obesity, metabolic disorders, neurology, neuropsychiatry, immunology, and inflammation. With approximately 400 employees, Nxera Pharma operates in key locations worldwide and is listed on the Tokyo Stock Exchange.
YTD Price Performance: -20.04%
Average Trading Volume: 749,193
Technical Sentiment Signal: Strong Sell
Current Market Cap: Yen75.84B
Find detailed analytics on 4565 stock on TipRanks’ Stock Analysis page.